Latest Safety News

ClearVue Technologies has secured Clean Energy Council approval for its ClearVue-Helios rooftop solar panels, enabling government subsidies and grid connection in Australia. This certification coincides with expanded commercial solar incentives, potentially lowering costs for customers.

Dimerix CEO Dr Nina Webster detailed the company’s geographic and product diversification at the Bioshares Summit, spotlighting the commercial potential of DMX-200 and the newly acquired Phase 2 asset DMX-652 targeting acute kidney injury.

Kinatico Limited reports a robust FY26 with SaaS revenue growth driving total revenue up 9.4% to $35.2 million and net profit after tax soaring 78.5% to $2.0 million, underpinned by its AI-native compliance platform.

Alliance Aviation Services has secured a materially improved wet lease agreement with Qantas, including higher pricing and a fleet reduction, while reaffirming its FY26 profit guidance amid operational realignment.

Clarity Pharmaceuticals reveals encouraging early results from the SECuRE trial, with substantial PSA reductions and multiple complete responses at the 8 GBq 67Cu-SAR-bisPSMA dose level in advanced prostate cancer patients.

Spacetalk Ltd has locked in $10 million through a two-tranche share placement, aiming to fund platform enhancements, inventory growth, and a major network migration.

AdAlta’s lead CAR-T therapy EW-001 has achieved a rare clinical milestone with one mesothelioma patient remaining cancer-free two years after treatment, and a second reaching one-year survival, underscoring the therapy’s potential durability in a notoriously difficult cancer.

Evolution Energy Minerals (ASX:EV1) has received official clearance from Tanzania’s Mining Commission to finalise its maiden drilling contract at the Chikundo Copper Project, advancing its local content strategy with three fully Tanzanian-owned contractors shortlisted.

WasteCo appoints Brian Cohalan as CEO effective August 31, replacing interim Roger Gower, alongside new regional managers and a COO resignation, signaling a strategic leadership reset.

HyTerra's McCoy-1 well production test in Kansas reveals low gas saturation but notable helium concentrations, prompting a pause on further testing at the site as the company refines its geologic hydrogen strategy.

Acusensus has landed a statewide contract in Kentucky to provide real-time speed enforcement at highway work zones, with initial orders worth US$2.1 million and potential expansion to US$20 million over five years.

Amplia Therapeutics has teamed up with Eli Lilly to test its FAK inhibitor narmafotinib alongside Lilly’s KRAS G12C inhibitor olomorasib in advanced non-small cell lung cancer, marking a strategic expansion beyond pancreatic and ovarian cancers.